Valproate inhibits MAP kinase signalling and cell cycle progression in S. cerevisiae
The mechanism of action of valproate (VPA), a widely prescribed short chain fatty acid with anticonvulsant and anticancer properties, remains poorly understood. Here, the yeast Saccharomyces cerevisiae was used as model to investigate the biological consequences of VPA exposure. We found that low pH...
Main Authors: | Desfossés-Baron, Kristelle, Hammond-Martel, Ian, Simoneau, Antoine, Sellam, Adnane, Roberts, Stephen, Wurtele, Hugo |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080547/ |
Similar Items
-
Chromosome-wide histone deacetylation by sirtuins prevents hyperactivation of DNA damage-induced signaling upon replicative stress
by: Simoneau, Antoine, et al.
Published: (2016) -
Recent advances on
Candida albicans biology and virulence
by: Sellam, Adnane, et al.
Published: (2016) -
Valproate-induced hyperammonemic encephalopathy: A reminder of rare complication of valproate
by: Gurjar, Mohan, et al.
Published: (2011) -
Use of naloxone in valproate overdose
by: Sanaei-Zadeh, Hossein
Published: (2012) -
West Syndrome: Response to Valproate
by: Chandra, Surabhi, et al.
Published: (2012)